ADCT- Adc Therapeutics SA

Name: Adc Therapeutics SA Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Adc Therapeutics SA (ADCT) has 15 insiders with recent SEC Form 4 filings, including 6 buys and 8 sells. ADCT is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
10%	Wild Hans Peter	9.79M	$36.07M	-
10%	Redmile Group, LLC	3.85M	$14.17M	-
CEO	Mallik Ameet	1.32M	$4.86M	-
CFO	Carmona Jose	488.7K	$1.80M	-
Other	Zaki Mohamed	421.8K	$1.55M	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Dec 11, 2024	Redmile Group, LLC47	10% Owner	Buy	200,000	$3.05	$609,000.00	+0.3%	-22.5%	+88.3%
Dec 4, 2024	Redmile Group, LLC47	10% Owner	Sell	25,352	$2.07	$52,478.64	-0.2%	-13.5%	+71.0%
Jul 1, 2024	Redmile Group, LLC47	10% Owner	Buy	800,000	$2.81	$2,248,000.00	+2.9%	-14.4%	-27.4%
Jun 17, 2024	Hug Peter	Director	Sell	1,193	$2.89	$3,447.77	-0.6%	+9.2%	+15.6%
Jun 17, 2024	Bizzari Jean-Pierre	Director	Sell	6,995	$2.89	$20,215.55	-8.1%	+9.2%	+15.6%
Jun 17, 2024	Monges Viviane	Director	Sell	1,437	$2.89	$4,152.93	-1.3%	+9.2%	+15.6%
Jun 17, 2024	Azelby Robert	Director	Sell	6,995	$2.89	$20,215.55	-11.7%	+9.2%	+15.6%
Jun 17, 2024	Sandor Victor	Director	Sell	6,995	$2.89	$20,215.55	-8.0%	+9.2%	+15.6%
Jun 17, 2024	Pfisterer Thomas	Director	Sell	1,437	$2.89	$4,152.93	-0.7%	+9.2%	+15.6%
Jun 17, 2024	Squarer Ron	Director	Sell	6,995	$2.89	$20,215.55	-8.0%	+9.2%	+15.6%

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC